Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Killock

Showing results (21-30 of 304) with videos related to

Pageof 31
Sort By:
Nature Reviews. Clinical Oncology|February 25, 2015
Neuroendocrine cancer: SELECT—lenvatinib in thyroid cancerDavid Killock
Nature Reviews. Clinical Oncology|November 12, 2014
Genetics: The Cancer Genome Atlas maps papillary thyroid cancerDavid Killock
Nature Reviews. Clinical Oncology|March 5, 2020
Moving pembrolizumab forwardsDavid Killock
Nature Reviews. Clinical Oncology|March 24, 2020
New standard for localized UTUCDavid Killock
Nature Reviews. Urology|March 24, 2020
New standard for localized UTUCDavid Killock
Nature Reviews. Clinical Oncology|January 23, 2020
AI outperforms radiologists in mammographic screeningDavid Killock
Nature Reviews. Clinical Oncology|January 5, 2020
AKT inhibition improves OS in TNBCDavid Killock
Nature Reviews. Clinical Oncology|July 22, 2024
BrECADD raises the bar in classical Hodgkin lymphomaDavid Killock
Nature Reviews. Clinical Oncology|April 24, 2025
Sacituzumab tirumotecan improves OS in mTNBCDavid Killock
Nature Reviews. Clinical Oncology|May 9, 2025
Next-generation KRAS-G12C inhibitor D3S-001 shows promiseDavid Killock
Pageof 31

Showing results (21-30 of 304) with videos related to

Sort By:
Pageof 31
Nature Reviews. Clinical Oncology|February 25, 2015
Neuroendocrine cancer: SELECT—lenvatinib in thyroid cancerDavid Killock
Nature Reviews. Clinical Oncology|November 12, 2014
Genetics: The Cancer Genome Atlas maps papillary thyroid cancerDavid Killock
Nature Reviews. Clinical Oncology|March 5, 2020
Moving pembrolizumab forwardsDavid Killock
Nature Reviews. Clinical Oncology|March 24, 2020
New standard for localized UTUCDavid Killock
Nature Reviews. Urology|March 24, 2020
New standard for localized UTUCDavid Killock
Nature Reviews. Clinical Oncology|January 23, 2020
AI outperforms radiologists in mammographic screeningDavid Killock
Nature Reviews. Clinical Oncology|January 5, 2020
AKT inhibition improves OS in TNBCDavid Killock
Nature Reviews. Clinical Oncology|July 22, 2024
BrECADD raises the bar in classical Hodgkin lymphomaDavid Killock
Nature Reviews. Clinical Oncology|April 24, 2025
Sacituzumab tirumotecan improves OS in mTNBCDavid Killock
Nature Reviews. Clinical Oncology|May 9, 2025
Next-generation KRAS-G12C inhibitor D3S-001 shows promiseDavid Killock
Pageof 31